Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Level 3 Communications, LLC, In the Matter of
Fantage.com, Inc., In the Matter of
Receivable Management Services Corporation, The, In the Matter of
Baker Tilly Virchow Krause, LLP, In the Matter of
Charles River Laboratories, Int’l., In the Matter of
Atlanta Falcons Football Club, LLC, In the Matter of
Tennessee Football, Inc., In the Matter of
Reynolds Consumer Products, Inc, In the Matter of
DDC Laboratories, Inc., also d/b/a DNA Diagnostics Center, In the Matter of
American Apparel, Inc., In the Matter of
Apperian, Inc., In the Matter of
BitTorrent, Inc., In the Matter of
DataMotion, Inc., a corporation, In the Matter of
ADT LLC, In the Matter of
Countrywide Periodicals, LLC
Akorn and Hi-Tech Pharmacal, In the Matter of
Akorn Enterprises, Inc. and Hi-Tech Pharmacal, Inc. agreed to sell the rights and assets to three generic prescription eye medications and two generic topical anesthetics to Watson Laboratories, Inc., to settle FTC charges that Akorn’s proposed $640 million acquisition of Hi-Tech would be anticompetitive and lead to higher prices for consumers. The proposed order requires the parties to sell either Akorn’s or Hi-Tech’s rights and assets to each of the five drug products to Watson, and requires Akorn to assign Watson its contract for making branded and generic EMLA cream within 10 days after the deal is consummated. In addition, the companies must maintain the drugs to be sold as viable, marketable, and competitive pending their divestiture, and must allow the FTC to appoint a monitor to ensure that the companies comply with the order’s requirements.